TNF Pharmaceuticals Inc. - Kapitalisasi Buku TNFA

The market trend for TNF Pharmaceuticals (TNFA) demonstrates asset dynamics where the indicator stands at 0.03. The business is currently restructuring its capital structure, betting on trials for treatments for metabolic immune disorders. TNF Pharmaceuticals (TNFA) is creating a closed system for treating age-related inflammation via unique inhibitors, while also implementing molecular anti-aging methods to extend the period of active longevity.

TNFA Kapitalisasi Buku TNF Pharmaceuticals, Inc. (25.07.2024 - 25.09.2025)

To objectively assess the fundamental value of assets, an investor must analyze the difference between net assets and total liabilities, as reflected in the value of 0.03. By analyzing the book capitalization trend, one can determine the extent to which the value of TNF Pharmaceuticals (TNFA) depends on tangible resources, such as the closed patent perimeter of the empresan platform and unique developments in the field of tumor necrosis factor inhibitors.

Analisis pesaing TNF Pharmaceuticals

HLN - Nilai Aset Bersih|KVUE: Kapitalisasi Buku|VRNA (veronapharma.com) - Kapitalisasi Buku|Nilai Buku Perusahaan Jyong Biotech MENS|Nilai Aset Bersih Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Kapitalisasi Buku|Nilai Akuntansi Perusahaan Perrigo Corp (PRGO)|Kapitalisasi Buku ALVO (Alvotech)|liquidia.com - Kapitalisasi Buku|Nilai Buku Perusahaan Galapagos (GLPG)|ANIP: Nilai Akuntansi Perusahaan|MNKD (MannKind Corp.) - Nilai Buku Perusahaan|Amphastar Corp (AMPH) - Aset Bersih Perusahaan|PCRX (Pacira BioSciences) - Kapitalisasi Buku|Kapitalisasi Buku ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan AQST (Aquestive Therapeutics Inc)|SCPH: Nilai Buku Perusahaan|TECX - Ekuitas Perusahaan|Aset Bersih Perusahaan Tonix Pharmaceuticals TNXP|SXTC - Total Aset Bersih|Kapitalisasi Buku eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Nilai Akuntansi Perusahaan|Kapitalisasi Buku EXOZ (Invizyne Technologies, Inc.)|Ekuitas Perusahaan ORMP|Entera Bio Ltd. (ENTX) - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan ipatherapeutics.com HYFT|Aset Bersih Perusahaan ABVC BioPharma, Inc. (ABVC)|Cumberland Pharmaceuticals Inc - Total Aset Bersih|Quantum BioPharma Limited (QNTM) - Nilai Buku Perusahaan|FGEN - Kapitalisasi Akuntansi|Kapitalisasi Buku Telomir Pharmaceuticals (TELO)|Nilai Aset Bersih Rani Therapeutics Holdings, Inc.|SNYR - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan RLYB|LEXX - Nilai Buku Perusahaan|Nilai Aset Bersih Pulmatrix Corporation (PULM)|Kapitalisasi Buku Pheton Holdings|Nilai Akuntansi Perusahaan Aptorum Group Ltd APM|Lyra Therapeutics - Kapitalisasi Buku|IBO: Kapitalisasi Buku|Nilai Buku Perusahaan cbdmd.com YCBD|PRFX (PainReform Corp) - Nilai Akuntansi Perusahaan|Nilai Buku Perusahaan CYTO|Aset Bersih Perusahaan lipella.com|Kapitalisasi Buku OPTN|Kapitalisasi Buku Pieris Pharmaceuticals Inc (PIRS)|Procaps Group SA - Kapitalisasi Buku|Aset Bersih Perusahaan Petros Pharma PTPI|QLI (Qilian International) - Kapitalisasi Buku|acelyrin.com (SLRN) - Ekuitas Perusahaan|TFFP: Aset Bersih Perusahaan